Cardiovascular Management with Bisoprolol

Introduction to Bisoprolol Therapy

Bisoprolol is effective for hypertension management at doses of 2.5-10 mg once daily, according to the American Heart Association 1
For optimal blood pressure control, the American College of Cardiology recommends monitoring blood pressure regularly, individualizing the target dose based on response, and considering combination with thiazide diuretics if additional BP control is needed 2

Bisoprolol is one of the recommended beta-blockers for heart failure with reduced ejection fraction, as stated by the American College of Cardiology, and should be started at low doses (1.25-2.5 mg) and gradually uptitrated 2
The American Heart Association recommends combining bisoprolol with ACE inhibitors/ARBs and aldosterone antagonists for optimal heart failure management, and monitoring for signs of worsening heart failure during initiation and dose adjustment 2

The American College of Cardiology advises against discontinuing bisoprolol before surgery, as perioperative beta-blockade reduces cardiac mortality and myocardial infarction in high-risk vascular surgery patients 4
For patients undergoing vascular surgery, the American Heart Association recommends continuing bisoprolol throughout the perioperative period to reduce cardiovascular complications 3

Recent evidence suggests that cardioselective beta-blockers like bisoprolol may be safe in select pulmonary arterial hypertension patients, according to the American College of Chest Physicians, and if PAH is present, consultation with a pulmonary hypertension specialist is recommended before initiating or continuing bisoprolol 5
The American Diabetes Association notes that beta-blockers may mask hypoglycemia symptoms in patients with diabetes, and therefore, careful monitoring is necessary 7

If discontinuation is required, the American College of Cardiology recommends implementing a gradual tapering schedule, reducing the dose by half every week for 3 weeks, and monitoring closely for angina symptoms or signs of cardiac ischemia during tapering 6
Increased vigilance is necessary in the first month after withdrawal when rebound phenomena are most common, as stated by the American Heart Association 6
The American College of Cardiology also recommends regular monitoring of blood pressure, heart rate, signs of heart failure, peripheral circulation, and renal function, especially if combined with ACE inhibitors or ARBs 2